Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Chimeras Derived from a P2Y14 Receptor Antagonist and UDP-Sugar Agonists for Potential Treatment of Inflammation

ACS Pharmacology & Translational Science(2024)10.1021/acsptsci.4c00489Source: DataRank Database

Chimeras Derived from a P2Y14 Receptor Antagonist and UDP-Sugar Agonists for Potential Treatment of Inflammation is a research paper published in ACS Pharmacology & Translational Science (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.96)OA: greenTopics (15)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Asmita Pramanik,Sarah A. Lewicki ORCID,Kwan‐Young Jung ORCID,Zhan-Guo Gao ORCID,John C.R. Randle

Live enrichment

PubMed:39421658 PMC:PMC11480895 OpenAlex:https://openalex.org/W4402859560

National Institute of Environmental Health Sciences

Grant: ZIAES102025

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: 17-0824

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: ZIADK31116

Intramural NIH HHS

Grant: ZIA DK031116

FWCI

1.96

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: https://doi.org/10.15223/policy-029

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11480895/pdf/pt4c00489.pdf

publisherhttps://pubs.acs.org/doi/pdf/10.1021/acsptsci.4c00489

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11480895/

journalhttps://doi.org/10.1021/acsptsci.4c00489

Fields of Study

Adenosine and Purinergic SignalingNeuropeptides and Animal PhysiologyPharmacological Receptor Mechanisms and Effects

Keywords

InflammationAntagonistSugarReceptorP2Y receptorChemistryPharmacologyCell biologyBiochemistryBiologyAgonistImmunology

Sustainable Development Goals

SDG 0: Good health and well-being

Chimeras Derived from a P2Y14 Receptor Antagonist and UDP-Sugar Agonists for Potential Treatment of Inflammation

FAIR Checklist

Authors (12)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)